Novel drugs targeting the androgen receptor pathway in prostate cancer
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
Novel drugs targeting the androgen receptor pathway in prostate cancer
J Mateo, A Smith, M Ong, JS Bono - Cancer and Metastasis Reviews, 2014 - infona.pl
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
Novel drugs targeting the androgen receptor pathway in prostate cancer.
J Mateo, A Smith, M Ong… - Cancer & Metastasis …, 2014 - search.ebscohost.com
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
Novel drugs targeting the androgen receptor pathway in prostate cancer
J Mateo, A Smith, M Ong… - Cancer metastasis …, 2014 - pubmed.ncbi.nlm.nih.gov
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
Novel drugs targeting the androgen receptor pathway in prostate cancer.
J Mateo, A Smith, M Ong, JS de Bono - Cancer Metastasis Reviews, 2014 - europepmc.org
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
Novel drugs targeting the androgen receptor pathway in prostate cancer
J Mateo, A Smith, M Ong… - Cancer and Metastasis …, 2014 - search.proquest.com
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
Novel drugs targeting the androgen receptor pathway in prostate cancer
J Mateo, A Smith, M Ong, JS de Bono - Cancer and Metastasis …, 2014 - hero.epa.gov
After decades of limited success in the treatment of castration-resistant prostate cancer
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …
(CRPC), five novel therapeutics were granted Food and Drug Administration regulatory …